A pathophysiology diagram illustrating the clinical impact of a Low-Calorie Ketogenic Diet (LCKD) protocol on adolescents with Polycystic Ovary Syndrome (PCOS). The schematic follows a linear progression from left to right. It begins with an adolescent figure representing a PCOS diagnosis, highlighting the pelvic region. The next stage depicts the 'LCKD protocol' intervention, which leads to the biochemical phase of 'Ketone bodies production,' represented by a molecular model. The final section branches into multiple physiological benefits, categorized by icons: a scale indicating weight loss and body composition improvement; a liver icon for lipid profile improvement; a blood drop for reduction in insulin resistance and oxidative stress; a calendar for menstrual regularity and hirsutism improvement; and a reproductive system icon for the reduction of androgen levels and LH/FSH ratios, alongside improved ovarian function. This infographic summarizes the multi-systemic metabolic and endocrine benefits of nutritional ketosis in managing PCOS symptoms.

This composite educational graphic illustrates the relationship between BOP1 expression and polycystic ovary syndrome (PCOS). Panel A presents an anatomical diagram of a transvaginal ultrasound procedure alongside two actual ultrasound images comparing a 'Normal' ovary to a 'PCOS' ovary. The PCOS ovary demonstrates classic diagnostic features including enlargement and a 'string of pearls' appearance with multiple peripherally located, small, hypoechoic antral follicles. Panels B through E are scatter plots with linear regression lines showing clinical correlations in PCOS patients. These graphs demonstrate that relative BOP1 mRNA expression in granulosa cells is negatively correlated with four key clinical indicators: Antral Follicle Count (AFC) (r = -0.6082), Body Mass Index (BMI) (r = -0.4798), Serum Testosterone levels (r = -0.4262), and Anti-Müllerian Hormone (AMH) levels (r = -0.4674). All correlations are statistically significant (p < 0.05). This visual data suggests that downregulation of the BOP1 gene is associated with increased severity of PCOS phenotypic markers and hormonal imbalances.

This pathophysiology diagram illustrates the differential regulation of inositol metabolism in classic insulin-responsive tissues versus the ovaries in Polycystic Ovary Syndrome (PCOS) with insulin resistance (IR). The top panel compares healthy and PCOS states in peripheral tissues. In healthy individuals, insulin binding to the insulin receptor activates the epimerase enzyme, facilitating the conversion of myo-inositol (MI) to D-chiro-inositol (DCI). In PCOS with IR, this conversion is blocked (indicated by an 'X'), leading to a 'Deficiency of DCI'. The bottom panel depicts the 'ovarian paradox'. In the ovary of a patient with PCOS and IR, hyperinsulinemia overstimulates the insulin receptor and the epimerase enzyme (indicated by a plus sign and thick arrows). This overactivity causes an excessive conversion of MI to DCI, resulting in a 'Pathological Increase of DCI'. The diagram uses chemical structures for MI and DCI and flow-based signaling pathways to explain how metabolic dysregulation in PCOS leads to tissue-specific inositol imbalances, contributing to endocrine dysfunction.

This pathophysiology diagram illustrates the neuroendocrine pathways linking the Hypothalamic-Pituitary-Gonadal (HPG) and Hypothalamic-Pituitary-Adrenal (HPA) axes in the context of Polycystic Ovary Syndrome (PCOS) and depression. The diagram shows a sagittal brain section highlighting the hypothalamus, where a decrease in inhibitory neurotransmitters (5-HT, GABA, DA, Ach) and an increase in glutamate lead to elevated GnRH pulses and CRH levels. This stimulates the anterior pituitary gland to increase LH secretion and the LH/FSH ratio, while simultaneously increasing ACTH. These hormonal shifts trigger the ovary to produce excessive testosterone (T) and estradiol (E2), and the adrenal gland to overproduce cortisol. The cascade culminates in clinical PCOS and depression, exacerbated by common pathological traits including obesity, insulin resistance, hyperandrogenism, inflammation, and infertility. Arrows indicate stimulatory pathways, while dashed lines represent disrupted negative feedback loops, providing a visual summary of hormonal dysregulation in gynecological and psychiatric co-morbidity.

This pathophysiology diagram illustrates the neuroendocrine pathways linking the Hypothalamic-Pituitary-Gonadal (HPG) and Hypothalamic-Pituitary-Adrenal (HPA) axes in the context of Polycystic Ovary Syndrome (PCOS) and depression. The diagram shows a sagittal brain section highlighting the hypothalamus, where a decrease in inhibitory neurotransmitters (5-HT, GABA, DA, Ach) and an increase in glutamate lead to elevated GnRH pulses and CRH levels. This stimulates the anterior pituitary gland to increase LH secretion and the LH/FSH ratio, while simultaneously increasing ACTH. These hormonal shifts trigger the ovary to produce excessive testosterone (T) and estradiol (E2), and the adrenal gland to overproduce cortisol. The cascade culminates in clinical PCOS and depression, exacerbated by common pathological traits including obesity, insulin resistance, hyperandrogenism, inflammation, and infertility. Arrows indicate stimulatory pathways, while dashed lines represent disrupted negative feedback loops, providing a visual summary of hormonal dysregulation in gynecological and psychiatric co-morbidity.

This pathophysiology diagram illustrates the dysregulation of the Androgen Receptor (AR) signaling pathway in the gravid uterus under conditions of hyperandrogenism and insulin resistance. A temporal comparison at the top shows that in normal pregnancy, AR expression transitions from moderate (yellow) during pre-implantation and implantation to low (black) post-implantation. In contrast, hyperandrogenism + insulin resistance maintains sustained high (red) AR expression across all stages. The cellular model depicts high AR expression (red star symbols) localized within the nucleus, cytoplasm, and mitochondrion. Nuclear AR translocation affects the transcription of implantation-related genes, including p21WAF1/CIP1, Spp1, Igfbp1, and Hoxa11, as well as Nr2f2, Ptch, Pgr, and Hbegf. Concurrently, mitochondrial AR localization and interaction with OXPHOS (Complex I/III), VDAC, PHB1, and Nrf1 contribute to mitochondrial malfunction. These combined molecular disturbances lead to abnormal implantation, compromised pregnancy outcomes, and subfertility, modeling mechanisms often associated with Polycystic Ovary Syndrome (PCOS).

A pathophysiology diagram illustrating the clinical impact of a Low-Calorie Ketogenic Diet (LCKD) protocol on adolescents with Polycystic Ovary Syndrome (PCOS). The schematic follows a linear progression from left to right. It begins with an adolescent figure representing a PCOS diagnosis, highlighting the pelvic region. The next stage depicts the 'LCKD protocol' intervention, which leads to the biochemical phase of 'Ketone bodies production,' represented by a molecular model. The final section branches into multiple physiological benefits, categorized by icons: a scale indicating weight loss and body composition improvement; a liver icon for lipid profile improvement; a blood drop for reduction in insulin resistance and oxidative stress; a calendar for menstrual regularity and hirsutism improvement; and a reproductive system icon for the reduction of androgen levels and LH/FSH ratios, alongside improved ovarian function. This infographic summarizes the multi-systemic metabolic and endocrine benefits of nutritional ketosis in managing PCOS symptoms.